Lamers F, et al
Diabetes Obes Metab 19(4):524536 Husain M, Bain SC, Holst AG, Mark T, Rasmussen S, Lingvay I (2020) Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
607 A randomized, double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological, and clinical measures in patients with T2DM with symptomatic polyneuropathy is undergoing
This approach is often used in performance enhancement, anti-aging, and regenerative medicine to maximize outcomes and support the body's healing and optimization processes more effectively
Because retatrutide is not yet commercially approved, there are no official prescribing guidelines for early dosing